O9A.112
Malignant neoplasm complicating pregnancy, second trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm complicating pregnancy, particularly during the second trimester, refers to a cancerous tumor that develops or is diagnosed during this specific stage of pregnancy. The presence of cancer during pregnancy presents unique challenges for both the mother and the unborn child, requiring careful medical management to balance treatment alongside ongoing pregnancy care. This condition is classified under ICD-10 code O9A.112, highlighting its significance within maternal health and oncology, and highlighting the importance of coordinated medical attention to optimize outcomes for mother and baby.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to uncontrolled cell growth Hormonal changes during pregnancy that may promote tumor development Environmental exposures to carcinogens such as chemicals or radiation Pre-existing cancer diagnosed during pregnancy Immune system alterations during pregnancy that might influence tumor behavior
Key Symptoms: Unexplained weight loss or gain Persistent fatigue or weakness Localized pain or discomfort depending on the tumor site Unusual bleeding or discharge Visible lumps or swelling Persistent nausea or vomiting not related to pregnancy Changes in skin appearance such as new moles or sores that do not heal
Diagnostic & Treatment
Diagnosis Path: Physical examination to identify abnormal lumps or changes Ultrasound imaging to visualize tumors while considering fetal safety Magnetic resonance imaging (MRI) without contrast for detailed imaging Biopsy procedures to confirm malignancy Laboratory tests, including blood counts and tumor markers, mindful of pregnancy safety Coordination with obstetrics and oncology specialists for comprehensive assessment
Treatment Protocols: Surgical intervention to remove tumors when feasible and safe during pregnancy Chemotherapy, carefully selected and timed to reduce risks during the second trimester when the fetus is less susceptible Radiation therapy typically avoided during pregnancy unless absolutely necessary Supportive care such as nutritional support and symptom management Close monitoring of both maternal and fetal well-being through regular obstetric assessments Postpartum ongoing cancer therapy if treatment was deferred or incomplete during pregnancy
Clinical Advice & FAQs
Billing Guidance
Is O9A.112 a billable ICD-10 code?
Yes, O9A.112 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O9A.112?
Clinical documentation must specify the nature of Malignant neoplasm complicating pregnancy, second trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference